Vicat : In an accumulation phase
Entry price | Target | Stop-loss | Potential |
---|
€38.3 |
€42 |
€36.3 |
+9.66% |
---|
After accumulation, acceleration. Timing appears favorable to go long in shares of Vicat and to anticipate an exit of the trading range on the upside.
Strengths● The share is getting closer to its long-term support in weekly data, at EUR 37.9, which offers good timing for buyers.
● The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
● With a P/E ratio at 11.82 for the current year and 10.46 for next year, earnings multiples are highly attractive compared with competitors.
● The company is one of the best yield companies with high dividend expectations.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses● The company is in debt and has limited leeway for investment
● The company's earnings releases usually do not meet expectations.
● Analysts covering the stock have recently lowered their earnings forecast.
● For the last few months, analysts have been revising downwards their earnings forecast.
● The underlying tendency is negative on the weekly chart below the resistance at 42.45 EUR
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.